Explore GoodRx's innovative new service designed to make pet care more affordable and accessible for pet owners.

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

Leerink Partners analyst Michael Cherny has maintained their bullish stance on GDRX stock, giving a Buy rating on January 10.Stay Ahead of the ...

GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) dropped 8.4% during trading on Monday after Citigroup lowered their price target on the stock from $7.00 to $6.25. Citigroup currently has a buy ...

GoodRx CEO Wendy Barnes discusses how telepharmacy firms navigate pricing and the outlook for obesity drugs with Katherine ...

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets ...

BofA lowered the firm’s price target on GoodRx (GDRX) to $4.25 from $4.50 and keeps an Underperform rating on the shares after the company ...

Pet owners now have a new online resource that can help them save money. GoodRx, a company known for offering consumers ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...

Analysts have set 12-month price targets for GoodRx Holdings, revealing an average target of $6.25, a high estimate of $7.00, ...